Search

everythinglearnresearchcommunity

for

Search:↓

Many patients with autoimmune blistering skin disorders change their diets, avoiding foods like alcohol, citrus, and spices, and some find vegetables and dairy helpful.

SLE patients need careful diagnosis to distinguish infections from disease flares for proper treatment.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Both patients and physicians are often dissatisfied with the control of systemic lupus erythematosus and lupus nephritis.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

IL-17 is a key target for treating inflammatory skin diseases, especially psoriasis.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

New technologies help us better understand how skin microbes affect skin diseases.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Effective symptom management in IBD improves quality of life and prevents complications.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Li2CO3 improved skin disease in a mouse model of Focal Dermal Hypoplasia without toxicity.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

An 18-year-old girl with pemphigus vulgaris needed strong medication and careful treatment due to ineffective initial therapies and side effects.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Finasteride reduces Hidradenitis Suppurativa flare-ups in children and teens, but long-term safety is unknown.

Different types of hair loss in lupus need careful diagnosis for proper treatment.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

Most lupus patients in the study experienced hair loss, which greatly affected their mental and social well-being.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

The skin's internal clock affects healing, cancer risk, aging, immunity, and hair growth, and disruptions can harm skin health.

Apremilast improved symptoms in patients with severe skin conditions.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.